Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

35.11
Delayed Data
As of 4:00pm ET
 -0.19 / -0.54%
Today’s Change
23.22
Today|||52-Week Range
40.29
-9.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$234.3M

Company Description

Heska Corp. engages in the research, development, and manufacture of veterinary products. It operates through the two segments: Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment supplies blood testing instruments, digital imaging software, heartworm diagnostic tests and preventive products, allergy immunotherapy products, and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment develops and distributes vaccines and pharmaceutical products. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Contact Information

Heska Corp.
3760 Rocky Mountain Avenue
Loveland Colorado 80538
P:(970) 493-7272
Investor Relations:

Employees

Shareholders

Other institutional46.73%
Individual stakeholders20.22%
Mutual fund holders15.36%

Top Executives

Kevin S. WilsonPresident, Chief Executive Officer & Director
Jason A. NapolitanoCOO, Chief Financial Officer, Secretary & EVP
Nancy WisnewskiEVP-Product Development & Customer Support
Michael J. McGinleyPresident-Biologicals & Pharmaceuticals
Steven M. EylExecutive Vice President-Commercial Operations